Bajaj Finance FY24 Annual Earnings Summary
4 quarters covered · ₹0 Cr revenue · ₹14,453 Cr PAT · 0.0% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Current-quarter results and commentary indicate the prior promise was delivered or materially on track.
Q2 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY24Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY24Risks flagged during the year
Management flagged that customers with multiple small-ticket loans (<₹50,000) show higher imprudence and default rates, prompting portfolio cuts of 8-14%.
Q3 FY24 · highRural B2C portfolio continues to show elevated delinquencies, with growth deliberately slowed to 10%. Management describes it as an 'inside-out problem' requiring ongoing risk actions.
Q3 FY24 · highRegulatory restrictions on two key products have temporarily impacted loan volumes and digital metrics. Full compliance submission is pending digital signature and vernacular KFS.
Q4 FY24 · highThe embargo on two products continues to impact loan bookings and AUM growth; timing of removal is uncertain.
Q1 FY24 · mediumManagement flagged increasing leverage in the system, especially in personal loans, and is taking preemptive actions to tighten underwriting.
Q1 FY24 · mediumRural B2C portfolio flagged as yellow due to elevated risk; business has been cut by INR 200-250 crore per month.
Q1 FY24 · mediumCost of funds rose 82 bps over three quarters, with NIM compression expected to continue for two more quarters.
Q2 FY24 · mediumCost of funds is expected to rise as low-cost borrowings mature and are replaced at higher rates, compressing NIM by 25-30 bps for the full year.
Q2 FY24 · mediumAnalyst raised concern about RBI's focus on unsecured loan growth; management acknowledged moderation in value but noted count growth remains elevated.
Q2 FY24 · mediumAnalyst asked about impact of possible risk weight hikes; management said they have levers to manage profitability but did not quantify impact.
Q3 FY24 · mediumAnalyst questioned whether rising delinquencies in urban B2C could persist. Management called it 'transient' but acknowledged preventive cuts of INR 450-500 crore quarterly.
Q3 FY24 · mediumRBI granted only a one-year renewal for the RBL Bank co-branded card partnership due to deficiencies. Management is engaging with RBI to resolve issues.
What changed through the year
Q1 FY24 · AUM growth of 29-31% for FY24
Management raised full-year AUM growth guidance from 27-29% to 29-31%, driven by strong Q1 momentum.
Q1 FY24 · Credit cost guidance of 155-165 bps for FY24
Full-year credit cost expected to be range-bound between 155-165 bps, including 6-8 bps from model redevelopment.
Q1 FY24 · NIM compression of 10-15 bps in Q2 and Q3
Net interest margin expected to compress by 10-15 bps each in Q2 and Q3 due to repricing of borrowings.
Q1 FY24 · New car financing to reach INR 200-250 crore per month by March 2024
New car financing business, launched in 80 cities, is expected to achieve monthly disbursements of INR 200-250 crore by exit of FY24.
Q2 FY24 · NIM compression of 25-30 bps expected for full year
Management guided for another 25-30 basis points of NIM compression over the remainder of FY24, driven by rising cost of funds and competitive pressure on yields.
Q2 FY24 · ROA to sustain at 5% on exit basis
Despite NIM compression, the company expects to sustain a return on assets of 5% on an exit basis for FY24, supported by operating leverage.
Q2 FY24 · Microfinance pilot to expand to 100 locations by March 2024
The microfinance pilot launched in 12 villages will scale to 100 locations by March 2024, with a target of 300 villages by March 2025.
Q2 FY24 · Capital raise of ₹10,000 crore via QIP and preferential allotment
Board approved raising ₹10,000 crore, comprising ₹8,800 crore through QIP and ₹1,200 crore preferential allotment to Bajaj Finserv, to support growth.
Q3 FY24 · Credit cost guidance of 175-185 bps
Management expects annualized loan losses to average AUM to remain in the 175-185 basis points range, consistent with pre-COVID levels.
Q3 FY24 · Interest rate hike of 20-30 bps from January 1
Effective January 1, the company increased interest rates by 20-30 basis points across portfolios to mitigate higher cost of funds and risk weights.
Q3 FY24 · Rural B2C growth slowed to 10%
Rural B2C portfolio growth was deliberately reduced to 10% in Q3 from 26% in Q1, reflecting risk actions to control elevated delinquencies.
Q3 FY24 · KFS compliance for all products by March 2024
The company plans to implement Key Fact Statement (KFS) in vernacular languages and digital signatures for all products by March 2024.
Q4 FY24 · AUM growth of 26%-28% in FY25
Management expects AUM to grow 26%-28% in FY25, supported by newly launched secured businesses like LAP, car finance, and tractor finance.
Q4 FY24 · NIM compression of 30-40 bps over next two quarters
Net interest margin is expected to moderate by 30-40 bps from current levels due to rising cost of funds and shift to secured assets, then stabilize.
Q4 FY24 · OpEx-to-income improvement of 20-40 bps
Operating expense to net interest income ratio is expected to improve by 20-40 bps from current levels as the company moves to consolidation.
Q4 FY24 · Credit costs within 175-185 bps corridor
Loan loss to average AUM is expected to remain in the 175-185 bps range, in line with pre-COVID levels adjusted for regulatory changes.